Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Motor Activity 32Breast Neoplasms 21Neoplasms 16Prostatic Neoplasms 11Obesity 8Sarcopenia 6Colorectal Neoplasms 6Pancreatic Neoplasms 5Lung Neoplasms 5Head and Neck Neoplasms 5Polycystic Ovary Syndrome 4Signs and Symptoms 3Multiple Myeloma 3Lymphedema 3Inflammation 3Fatigue 3Diabetes Mellitus, Type 2 3Colonic Neoplasms 3Brain Neoplasms 3Uterine Cervical Neoplasms 2Pharyngeal Neoplasms 2Overweight 2Osteoporosis, Postmenopausal 2Osteoporosis 2Lymphoma 2Leukemia, Myeloid, Acute 2Leukemia 2Laryngeal Neoplasms 2Insulin Resistance 2Hematopoietic and Lymphatic System Neoplasm 2

Interventions

Megestrol Acetate 7Medroxyprogesterone Acetate 4Progestins 3Metformin 3Tirzepatide 2Progesterone 2Letrozole 2Biopsy 2Atorvastatin 2semaglutide 1ricin A-GnRH conjugate 1exemestane 1estradiol, norethindrone drug combination 1Tamoxifen 1Rosuvastatin Calcium 1Resistance Training 1Pterocarpus marsupium 1Pharmacogenomic Variants 1Nutrition Assessment 1Magnetic Resonance Spectroscopy 1Levonorgestrel 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Hysteroscopy 1Hysterectomy 1Hydroxymethylglutaryl-CoA Reductase Inhibitors 1Gonadotropin-Releasing Hormone 1Genetic Testing 1Everolimus 1Estrogen Replacement Therapy 1Cyproterone acetate, ethinyl estradiol drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Endometrial Hyperplasia × Resistance Training × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡